EZYGO BOTTLE

Main information

  • Trade name:
  • EZYGO BOTTLE 100 GM
  • Dosage:
  • 64.5WITH SARJIKA KSHAR 8.5%,NIMBU SATBA 10;%
  • Composition:
  • 100 GM
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EZYGO BOTTLE 100 GM
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

18-4-2018

24-Hour Multi-Patient Use Endoscope Connectors: Letter to HealthCare Providers and Healthcare Facilities - Risk of Cross-Contamination

24-Hour Multi-Patient Use Endoscope Connectors: Letter to HealthCare Providers and Healthcare Facilities - Risk of Cross-Contamination

the recommended instructions and device design for the ERBEFLO port connector do not adequately mitigate the risks of cross-contamination for endoscopy patients. This is because the connector, tubing, and/or water bottle can become contaminated with blood, stool, or other fluids from previous patients that travel back through the endoscope channels into the connector and tubing. Endoscope connectors that are labeled for use with multiple patients over the course of 24 hours without reprocessing are kno...

FDA - U.S. Food and Drug Administration

22-1-2018

Magno-Humphries Laboratories, Inc., Issues Voluntary Nationwide Recall of Basic Drugs Brand of Senna Laxative Due to Mislabeling

Magno-Humphries Laboratories, Inc., Issues Voluntary Nationwide Recall of Basic Drugs Brand of Senna Laxative Due to Mislabeling

Tigard, OR, Magno-Humphries Laboratories, Inc., is voluntarily recalling one lot of Basic Drugs Brand of Senna Laxative tablets, 8.6mg Sennosides to the consumer level due to a customer complaint that their bottle labeled as Senna Laxative actually contained Basic Drugs Brand of Naproxen Sodium 220mg. Naproxen Sodium 220mg tablet is used as a pain reliever and is a nonsteroidal anti-inflammatory drug (NSAID).

FDA - U.S. Food and Drug Administration

12-1-2018

Flintstones Plus Iron multivitamins for children: One bottle found to contain unidentified capsules instead of chewable tablets

Flintstones Plus Iron multivitamins for children: One bottle found to contain unidentified capsules instead of chewable tablets

Health Canada is advising Canadians that one bottle of children’s “Flintstones Plus Iron” multivitamins (NPN 02247995) was returned to a pharmacy containing unidentified capsules instead of the proper chewable tablets, which are multi-coloured tablets shaped like Flintstones characters. The opened bottle with the safety seal removed was returned to a Pharmaprix in Longueuil, QC, in December 2017.

Health Canada

6-10-2017

Kiriko, LLC. Issues Voluntary Nationwide Recall of A1 Slim Due to Undeclared Sibutramine, Phenolphthalein and N-Desmethyl sibutramine

Kiriko, LLC. Issues Voluntary Nationwide Recall of A1 Slim Due to Undeclared Sibutramine, Phenolphthalein and N-Desmethyl sibutramine

, Kiriko, LLC. is voluntarily recalling all lots of A1 Slim 30 capsules bottle to the consumer level. FDA laboratory analysis has found the A1 Slim product to be tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine.

FDA - U.S. Food and Drug Administration

21-7-2017

Ultra Shop Supplement Issues Voluntary Nationwide Recall of Super Panther 7K Due to Presence of Undeclared Sildenafil and Tadalafil

Ultra Shop Supplement Issues Voluntary Nationwide Recall of Super Panther 7K Due to Presence of Undeclared Sildenafil and Tadalafil

Charlotte, NC, Ultra Shop Supplement is voluntarily recalling Super Panther 7K capsules, [1 count blister card Lot#: RO846356 and 6 count bottle Lot RO246852 within expiry], distributed by SX Power Co., Brooklyn, NY, to the consumer level. FDA analysis found samples of Super Panther 7K to be tainted with undeclared sildenafil and tadalafil, active ingredients in two FDA-approved prescription drug products, also known as phosphodiesterate 5-inhibitors (PDE-5), used to treat erectile dysfunction (ED).

FDA - U.S. Food and Drug Administration

17-6-2017

Update to Voluntary Recall of Eliquis® (apixaban) 5 mg Tablets (#HN0063) - Recall to retail/dispensing level only

Update to Voluntary Recall of Eliquis® (apixaban) 5 mg Tablets (#HN0063) - Recall to retail/dispensing level only

On June 10, Bristol-Myers Squibb announced a voluntary recall of one lot (#HN0063) of Eliquis 5 mg tablets. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a single customer complaint that a bottle labeled as Eliquis5 mg was found to contain Eliquis 2.5 mg tablets. No other lots are impacted by this recall.

FDA - U.S. Food and Drug Administration

13-6-2017

Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

Patients should not stop taking Eliquis without consulting with their physician

FDA - U.S. Food and Drug Administration

13-6-2017

Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets

Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets

Bristol-Myers Squibb Company (NYSE: BMY) is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets.

FDA - U.S. Food and Drug Administration

26-5-2017

Astrazeneca Initiates Voluntary Nationwide Recall of One Lot of Brilinta 90 mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle From That Lot

Astrazeneca Initiates Voluntary Nationwide Recall of One Lot of Brilinta 90 mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle From That Lot

AstraZeneca today announced that the Company is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of BRILINTA (ticagrelor) 90mg tablets as a precautionary measure. This voluntary recall follows a report that a professional sample bottle containing eight tablets of BRILINTA 90mg also contained another medicine called ZURAMPIC (lesinurad) 200 mg tablets which is also manufactured by AstraZeneca.

FDA - U.S. Food and Drug Administration

26-5-2017

Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 - Due to Report of Another Medicine in One Bottle

Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 - Due to Report of Another Medicine in One Bottle

Unintentional dosing with Zurampic has the potential to lead to adverse renal effects including acute renal failure.

FDA - U.S. Food and Drug Administration

5-5-2017

Genetic Edge Compounds Issues Voluntary Nationwide Recall of GEC Laxoplex Dietary Supplement Capsules Due to Presence of Anabolic Steroids

Genetic Edge Compounds Issues Voluntary Nationwide Recall of GEC Laxoplex Dietary Supplement Capsules Due to Presence of Anabolic Steroids

Genetic Edge Compounds is voluntarily recalling all lot codes distributed between February 2, 2015- May 2, 2017 of GEC Laxoplex dietary supplement capsules, packaged in a white plastic bottle containing 60 capsules to the retail level and consumer level. Food and Drug Administration (“FDA”) analysis has found GEC Laxoplex to be tainted with anabolic steroids and steroid like substances.

FDA - U.S. Food and Drug Administration

29-12-2017

UP AND UP FIBER THERAPY (Psyllium Husk) Powder [Target Corporation]

UP AND UP FIBER THERAPY (Psyllium Husk) Powder [Target Corporation]

Updated Date: Dec 29, 2017 EST

US - DailyMed

29-12-2017

UP AND UP FIBER THERAPY NATURAL FIBER (Psyllium Husk) Powder [Target Corporation]

UP AND UP FIBER THERAPY NATURAL FIBER (Psyllium Husk) Powder [Target Corporation]

Updated Date: Dec 29, 2017 EST

US - DailyMed

14-6-2017

NATURAL DAILY FIBER (Psyllium Husk) Capsule [CVS Pharmacy,Inc.]

NATURAL DAILY FIBER (Psyllium Husk) Capsule [CVS Pharmacy,Inc.]

Updated Date: Jun 14, 2017 EST

US - DailyMed